Janus Henderson Global Life Sciences Fund Class S (JFNSX)
| Fund Assets | 5.54B |
| Expense Ratio | 1.18% |
| Min. Investment | $2,500 |
| Turnover | 30.00% |
| Dividend (ttm) | 3.51 |
| Dividend Yield | 4.77% |
| Dividend Growth | -5.57% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 5, 2025 |
| Previous Close | 73.61 |
| YTD Return | -2.90% |
| 1-Year Return | 22.37% |
| 5-Year Return | 41.15% |
| 52-Week Low | 58.49 |
| 52-Week High | 80.39 |
| Beta (5Y) | n/a |
| Holdings | 103 |
| Inception Date | Jul 6, 2009 |
About JFNSX
Janus Henderson Global Life Sciences Fund Class S is an open-ended mutual fund specializing in equities within the global life sciences sector. Its primary purpose is to provide long-term capital growth by allocating at least 80% of assets to companies with a life sciences orientation—such as those focused on healthcare, biotechnology, pharmaceuticals, medical devices, and health care services—across any market capitalization and region. The fund actively seeks companies that address unmet medical needs or aim to make health care delivery more efficient, maintaining diversification not only geographically but also across industry subsectors. It is managed by a team of healthcare and scientific specialists employing a disciplined investment and risk management process, with reference to but not limited by the MSCI World Health Care Index. The fund’s holdings typically include leading global healthcare firms and innovators, reflecting its emphasis on sectors and businesses poised to benefit from advancements in science, technology, and the evolution of healthcare systems worldwide.
Performance
JFNSX had a total return of 22.37% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.43%.
Top 10 Holdings
38.92% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.26% |
| Johnson & Johnson | JNJ | 6.37% |
| AstraZeneca PLC | AZN | 4.27% |
| AbbVie Inc. | ABBV | 3.39% |
| UnitedHealth Group Incorporated | UNH | 3.03% |
| Novartis AG ADR | NVSN.MX | 2.67% |
| argenx SE | ARGX | 2.65% |
| Roche Holding AG | ROG | 2.43% |
| Praxis Precision Medicines, Inc. | PRAX | 2.43% |
| Abbott Laboratories | ABT | 2.41% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 5, 2025 | $3.50786 | Dec 5, 2025 |
| Dec 6, 2024 | $3.71459 | Dec 6, 2024 |
| Dec 7, 2023 | $2.85171 | Dec 7, 2023 |
| Dec 20, 2021 | $6.57436 | Dec 20, 2021 |
| Dec 17, 2020 | $5.35765 | Dec 17, 2020 |
| Dec 17, 2019 | $3.63608 | Dec 17, 2019 |